LIMINAL COLLECTIVE LLC – Trademark Portfolio
Entity Type: 16
LIMINAL COLLECTIVE LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 3 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include LIMINAL COLLECTIVE. The owner is based in LAS VEGAS, NV.
9360 W. FLAMINGO RD., SUITE 110, #449
LAS VEGAS, NV 89147
Showing of trademarks Trademarks
Trademark Classifications
LIMINAL COLLECTIVE LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does LIMINAL COLLECTIVE LLC have?
LIMINAL COLLECTIVE LLC has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does LIMINAL COLLECTIVE LLC file in?
LIMINAL COLLECTIVE LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 35 (Advertising & Business). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are LIMINAL COLLECTIVE LLC's most well-known trademarks?
LIMINAL COLLECTIVE LLC's registered trademark portfolio includes well-known marks such as LIMINAL COLLECTIVE. These are among 3 currently registered trademarks in the portfolio.
What is LIMINAL COLLECTIVE LLC's trademark registration success rate?
LIMINAL COLLECTIVE LLC has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.